3BHANA N,GOA K L,MCCLELLAN K J.Dexmedetomidine[J].Drugs,2000,59:263-268. 被引量:1
4ANTTILA M,PENTTILA J,HELMINEN A,et al.Bioavailability of dexmedetomidine after extravascular doses in healthy subjects[J].Br J Clin pharmacol,2003,56(6):691-693. 被引量:1
5MAZE M,SCARFINI C,CAVALIERE F.New agents for sedation in the intensive care unit[J].Crit Care Clin,2001,17:881-897. 被引量:1
6NELSON L E,LU J,GUO T Z,et al.The α2-Adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J].Anesthesiology,2003,98:428-436. 被引量:1
7COULL J T,JONESM,EGAN T,et al.Attentional effects of noradrenaline vary with arousal level:selective activation of thalamic pulvinar in humans[J].Neuro Image,2004,22:315-322. 被引量:1
9EISENACH J C.[Alpha]2 agonists and analgesia[J].Exp Opin InvestD rugs,1994,3:1005-1010. 被引量:1
10SHEHABI Y,RUETTIMANN U,ADAMSON H,et al.Dexmedetomidine infusion for morethan 24 hours in critically ill patients:sedative and cardiovascular effects[J].Intensive caro medicine,2004,30(12):2188-2196. 被引量:1